Regeneron Pharmaceuticals

Regeneron Pharmaceuticals as of Sept. 30, 2025

Portfolio Holdings for Regeneron Pharmaceuticals

Regeneron Pharmaceuticals holds 4 positions in its portfolio as reported in the September 2025 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Alnylam Pharmaceuticals Common Stock (ALNY) 90.6 $635M 1.4M 456.00
Intellia Therapeutics Common Stock (NTLA) 9.1 $64M 3.7M 17.27
Adverum Biotechnologies Common Stock (ADVM) 0.1 $820k 181k 4.53
Adicet Bio Common Stock (ACET) 0.1 $784k 968k 0.81